Evaluation of the protective efficacy of reshaped human monoclonal antibody RSHZ19 against respiratory syncytial virus in cotton rats

Clicks: 459
ID: 110516
1995
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Reshaped human MAb RSHZ19, which is specific for the surface fusion protein of respiratory syncytial virus (RSV) is in clinical development for the prevention and treatment of RSV-induced disease in human infants. The current studies profile lung virus clearance and evaluate lung histopathology in M …
Reference Key
pr1995pediatricevaluation Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Wyde PR;Moore DK;Hepburn T;Silverman CL;Porter TG;Gross M;Taylor G;Demuth SG;Dillon SB;;
Journal Pediatric research
Year 1995
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/8559607
Keywords
immunization National Center for Biotechnology Information NCBI NLM MEDLINE animals humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't u.s. gov't Disease Models Animal Infant Comparative Study P.H.S. Antibodies Monoclonal Humanized respiratory syncytial viruses / immunology* pmid:8559607 doi:10.1203/00006450-199510000-00012 p r wyde d k moore s b dillon monoclonal / pharmacokinetics monoclonal / pharmacology* monoclonal / therapeutic use viral / blood bronchoalveolar lavage fluid / immunology evaluation studies as topic passive in vitro techniques lung / pathology neutralization tests respiratory syncytial virus infections / immunology respiratory syncytial virus infections / prevention & control* respiratory syncytial virus infections / therapy sigmodontinae viral fusion proteins / immunology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.